← Back to all trials
Recruiting
NCT07449403
SII Levels Following PENG Block in Hip Arthroplasty
Conditions: Hip Osteoarthritis
Sex: All
Ages: 65 Years – 100 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Poznan University of Medical Sciences
Location: Poznan University of Medical Sciences Poznan
Summary
This randomized controlled trial evaluates the effect of ultrasound-guided Pericapsular Nerve Group (PENG) block on the Systemic Immune-Inflammation Index (SII) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SII, calculated as platelet × neutrophil / lymphocyte count, is used as a composite marker of perioperative inflammatory and immune response. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.
Eligibility Criteria
Inclusion Criteria:
* Patients with ASA classification I-III
* Aged 65-100 years
* Who will be scheduled for hip arthroplasty under spinal anesthesia
Exclusion Criteria:
* Patients who have a history of bleeding diathesis
* Take anticoagulant therapy
* History of chronic pain before surgery
* Multiple trauma
* patients unable to assess their pain (dementia)
* patients operated under general anesthesia
* patients having an infection in the region of the procedure
* the patient who does not accept the procedure
Source: ClinicalTrials.gov (NCT07449403). StuddyBuddy aggregates publicly available trial information.